Scynexis (SCYX) Non-Current Assets (2013 - 2026)
Scynexis (SCYX) reported Non-Current Assets of $14.9 million for Q1 2026, down 4.84% on a YoY basis from $15.7 million in Q1 2025, and down 19.93% quarter-over-quarter from $18.7 million in Q4 2025.
Scynexis (SCYX) Non-Current Assets (2013 - 2026) Analysis & Trends
Scynexis has reported Non-Current Assets for 14 years, with the latest figure at $14.9 million in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Assets fell 4.84% year-over-year to $14.9 million; the trailing twelve-month figure through Mar 2026 stood at $40.2 million (down 39.11% YoY), and the FY2025 full-year result was $18.7 million, up 1.03% from the prior year.
- Non-Current Assets for Q1 2026 stood at $14.9 million, down from $18.7 million in the prior quarter.
- The five-year high for Non-Current Assets was $26.3 million in Q4 2023, with the low at $2.4 million in Q3 2025.
- Historically, Non-Current Assets has averaged $13.3 million across 5 years, with a median of $13.2 million in 2024.
- Annual changes were most pronounced in 2023 — Non-Current Assets jumped 200.56% — and 2025, when it tumbled 87.2%.
- Scynexis' Non-Current Assets stood at $8.7 million in 2022, then jumped by 200.56% to $26.3 million in 2023, then declined by 29.79% to $18.5 million in 2024, then climbed by 1.03% to $18.7 million in 2025, then retreated by 19.93% to $14.9 million in 2026.
- The last three Non-Current Assets figures came in at $14.9 million (Q1 2026), $18.7 million (Q4 2025), and $2.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 26.33 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 8.68 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 3.84 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 2.47 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 9.64 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 2.90 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 1.22 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.40 Bn |
| 10 | Scynexis | 225.23 Mn | 165.97 Mn | - | 14.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.94 Mn |
| Dec 31, 2025 | 18.65 Mn |
| Sep 30, 2025 | 2.38 Mn |
| Jun 30, 2025 | 4.20 Mn |
| Mar 31, 2025 | 15.69 Mn |
| Dec 31, 2024 | 18.46 Mn |
| Sep 30, 2024 | 18.58 Mn |
| Jun 30, 2024 | 13.23 Mn |
| Mar 31, 2024 | 16.58 Mn |
| Dec 31, 2023 | 26.30 Mn |
| Sep 30, 2023 | 19.91 Mn |
| Jun 30, 2023 | 9.33 Mn |
| Mar 31, 2023 | 10.53 Mn |
| Dec 31, 2022 | 8.75 Mn |
| Sep 30, 2022 | 8.73 Mn |
| Jun 30, 2022 | 9.94 Mn |
| Mar 31, 2022 | 9.66 Mn |
| Dec 31, 2021 | 10.46 Mn |
| Sep 30, 2021 | 5.95 Mn |
| Jun 30, 2021 | 5.50 Mn |